Effect of Preoperative Aspirin in Patients Undergoing Off-pump Coronary Artery Bypass Grafting
NCT ID: NCT03049085
Last Updated: 2017-02-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
300 participants
INTERVENTIONAL
2017-02-01
2019-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy and Safety of Aspirin Therapy With CABG
NCT02942680
Comparing High and lOw-dose asPirin With Dual anTIplatelet Therapy for Three Months Using prasUgrel and aSpirin Following Coronary Artery Bypass Grafting. (OPTIMUS-CABG Trial)
NCT07195149
Optimal Dose of Acetylsalicylic Acid After Coronary Artery Bypass Grafting
NCT02482857
Vitamin C in Cardiac Surgery Patients
NCT03123107
Colchicine in Patients Undergoing Coronary Artery Bypass Grafting After Acute Coronary Syndrome
NCT05726019
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Aspirin group
a 75 mg uncoated aspirin is administered 2 hours prior to OPCAB
Aspirin
preoperative uncoated 75 mg Aspirin is administered 2 hours prior OPCAB
Placebo group
75 mg Vit. C is administered 2 hours prior OPCAB
vitamin C
preoperative 75 mg Vit. C (Placebo) is administered 2 hours prior OPCAB
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Aspirin
preoperative uncoated 75 mg Aspirin is administered 2 hours prior OPCAB
vitamin C
preoperative 75 mg Vit. C (Placebo) is administered 2 hours prior OPCAB
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients in whom antiplatelet therapy was stopped 5-7 days prior to OPCAB
Exclusion Criteria
* Patients in whom antiplatelet therapy was not stopped 5-7 days prior to OPCAB
* Intraoperative conversion to on-pump coronary artery bypass grafting
* Patients with inherited blood-clotting disorders
* Patients undergoing other cardiac operations
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medinet Heart Centre
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medinet Heart Centre
Nowa Sól, Lubusz Voivodeship, Poland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Preoperative aspirin-OPCAB
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.